knowledge -WSS

knowledge

author：comprehensive 2025-09-07 17:23:33 - browse：8389

Axovant Sciences(AXON) is the main event in biotech’s September cavalcade of clinical trial readouts, but while we wait, it’s a good idea to prep for important — and stock-moving — data releases from Zogenix(ZGNX) and Amicus Therapeutics(FOLD).

Zogenix’s lead drug, called ZX008, is a low-dose liquid formulation of the old serotonin booster fenfluramine. The company is developing ZX008 to treat children with Dravet syndrome, a rare and severe type of epilepsy.

You might remember fenfluramine as part of the “fen-phen” obesity regimen that was pulled from the market in 1997 because fenfluramine (at a higher dose) caused severe damage to people’s heart valves.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Supreme Court strikes down Biden student loan forgiveness program

WSS

Brazil's Jair Bolsonaro is barred from running for office until 2030

Vertex non

EQRx, failed developer of low

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Lawsuit alleges UnitedHealth Group unit illegally denied claims

leisure time

knowledge

hotspot

Heart attack and stroke risk calculators need revising

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

Duchenne breakthrough therapy leaves behind pioneering families

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

How one medical school became remarkably diverse

‘Oppenheimer’ and the risks of AI in health care

After affirmative action ruling, medical educators look to 'holistic review'

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Dobbs anniversary: the lost opportunity of abortion as health care

Synthetic human embryos? Researchers say term is overblown

hotspot

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Eating disorder hotline's move to chatbot carried cost for volunteers

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

hotspot

hotspot

entertainment

explore